With the massive surge in the use of GLP-1 medications like Semaglutide and Tirzepatide, more people than ever are achieving their goal weight
Tirzepatide: FDA approved and widely available Tirzepatide received FDA approval for type 2 diabetes (as Mounjaro) in 2022 and for chronic weight management (as Zepbound) in 2023
We collaborate with insurers such as UnitedHealthcare, Cigna, Blue Cross Blue Shield, Aetna, and even federal programs like Medicare Part D and Medicaid, all dependent on state restrictions
Even so, that brand did not meet even this inconsequential amount, having only 1 mg instead of 2 mg
Following the superhuman protocol may lead to faster recovery and improved athletic performance, as well as offer a plethora of other benefits